Ring chromosome 19 syndrome

Ring chromosome 19 syndrome (also known as r(19) syndrome) is a rare chromosomal disorder in which one copy of chromosome 19 forms a ring structure, typically resulting from breakage and reunion at both ends of the chromosome with loss of genetic material from the distal portions. This structural rearrangement leads to a variable clinical phenotype depending on the amount of chromosomal material deleted during ring formation and the degree of ring instability, which can cause mosaic monosomy or other secondary rearrangements in dividing cells. The syndrome primarily affects the nervous system, with epilepsy being the most prominent and consistent clinical feature. Seizures are often early-onset, can be refractory to standard antiepileptic medications, and may include multiple seizure types. Intellectual disability ranging from mild to severe is commonly observed, along with behavioral difficulties. Additional features may include mild facial dysmorphism, microcephaly, growth retardation, and speech and language delays. Some patients may also exhibit features overlapping with other chromosome 19-related conditions depending on the specific breakpoints involved. There is no cure for ring chromosome 19 syndrome. Management is primarily supportive and symptomatic, focusing on seizure control with antiepileptic drugs, although seizures may be difficult to manage. Early intervention programs including speech therapy, occupational therapy, physical therapy, and special educational support are important components of care. Regular developmental and neurological monitoring is recommended. Genetic counseling is advised for affected families to discuss recurrence risks and the nature of the chromosomal abnormality.

Common questions about Ring chromosome 19 syndrome